FDA Drug Application (202014) for NORETHINDRONE by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number202014
Product Number001
FormTABLET;ORAL-28
Dosage0.35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNORETHINDRONE
Active IngredientNORETHINDRONE



Back to FDA Applications sponsored by NOVAST LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.